These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11813929)

  • 1. Review of cefditoren, an advanced-generation, broad-spectrum oral cephalosporin.
    Guay DR
    Clin Ther; 2001 Dec; 23(12):1924-37; discussion 1923. PubMed ID: 11813929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefdinir: an advanced-generation, broad-spectrum oral cephalosporin.
    Guay DR
    Clin Ther; 2002 Apr; 24(4):473-89. PubMed ID: 12017394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefdinir: an expanded-spectrum oral cephalosporin.
    Guay DR
    Ann Pharmacother; 2000 Dec; 34(12):1469-77. PubMed ID: 11144705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefditoren pivoxil.
    Darkes MJ; Plosker GL
    Drugs; 2002; 62(2):319-36; discussion 337-8. PubMed ID: 11817976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefditoren pivoxil: a review of its use in the treatment of bacterial infections.
    Wellington K; Curran MP
    Drugs; 2004; 64(22):2597-618. PubMed ID: 15516158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftibuten: a new expanded-spectrum oral cephalosporin.
    Guay DR
    Ann Pharmacother; 1997 Sep; 31(9):1022-33. PubMed ID: 9296244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on cefditoren pivoxil in bacterial infections.
    Wellington K; Curran MP
    Treat Respir Med; 2005; 4(2):149-52. PubMed ID: 15813670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
    Johnson DM; Biedenbach DJ; Beach ML; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jun; 37(2):99-105. PubMed ID: 10863104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefditoren, a new aminothiazolyl cephalosporin.
    Balbisi EA
    Pharmacotherapy; 2002 Oct; 22(10):1278-93. PubMed ID: 12389878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):202-12. PubMed ID: 19321284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefditoren in vitro activity and spectrum: a review of international studies using reference methods.
    Jones RN; Pfaller MA; Jacobs MR; Appelbaum PC; Fuchs PC
    Diagn Microbiol Infect Dis; 2001; 41(1-2):1-14. PubMed ID: 11687308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cefditoren pivoxil: A new oral cephalosporin for skin, soft tissue and respiratory tract infections].
    Hernández-Martin J; Romá E; Salavert M; Doménech L; Poveda JL
    Rev Esp Quimioter; 2006 Sep; 19(3):231-46. PubMed ID: 17099791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of in vitro activity, pharmacokinetic characteristics, safety, and clinical efficacy of cefprozil, a new oral cephalosporin.
    Barriere SL
    Ann Pharmacother; 1993 Sep; 27(9):1082-9. PubMed ID: 8219444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM; Scott LJ
    Drugs; 2004; 64(13):1433-64. PubMed ID: 15212560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telithromycin: the first ketolide antimicrobial.
    Nguyen M; Chung EP
    Clin Ther; 2005 Aug; 27(8):1144-63. PubMed ID: 16199242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
    Tempera G; Furneri PM; Carlone NA; Cocuzza C; Rigoli R; Musumeci R; Pilloni AP; Prenna M; Tufano MA; Tullio V; Vitali LA; Nicoletti G
    J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of oral extended-spectrum cephems in the treatment of acute exacerbation of chronic bronchitis.
    Anzueto A; Bishai WR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):31S-38S. PubMed ID: 17349461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D; Robbins MJ; Ghosh G; Bhogal H; Mehta MD; Leakey A; Clark S; Dencer CA; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1994; 20(4):127-47. PubMed ID: 7813385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cefprozil. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic potential.
    Wiseman LR; Benfield P
    Drugs; 1993 Feb; 45(2):295-317. PubMed ID: 7681376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.